Table 1.
Characteristic | 1 | 2 | 3 | 4 |
---|---|---|---|---|
Morphology | ||||
Size (in SYPHC medium) [μm] |
1.2 – 2.2 × 0.6 |
1.2 – 1.8 × 0.7 |
1.2 – 1.5 × 0.6 |
1.2 -1.6 × 0.6 |
Shape (in SYPHC medium) |
straight-to-bent rods, coccoid |
straight-to-bent rods, coccoid |
straight rods, coccoid |
straight rods, coccoid |
Storage compounds |
PolyP, PHA |
PolyP, PHA |
PolyP, CP |
PolyP, GLY |
Motility |
- |
+ |
+ |
- |
Cell aggregation |
- |
w |
+ |
+ |
Pigmentation | ||||
BChl a absorption [nm] (in vivo) |
801, 871 |
802, 877 |
802, 876 |
804, 821, 871 |
BChl a production [nmol/mg dw] |
1.2 |
1.1* |
3.5 |
4.4 |
Carotenoid absorption [nm] (in acetone/methanol) |
465, 495, 529 |
467, 496, 531 |
465, 495, 529 |
470, 496, 530 |
Diffusible brown compound |
- |
+ |
- |
- |
Chemotaxonomy | ||||
Fatty acid 16:1 ω6c |
- |
- |
+ |
- |
Main hydroxy fatty acids (>1% of total fatty acids) |
10:0 3OH, 12:0 3OH |
11:0 3OH, 12:0 3OH, 12:1 3OH |
10:0 3OH |
12:1 3OH, 12:0 2OH |
Lipoquinones |
Q8 (tr. Q7) |
Q8 |
Q8 |
Q8* |
Polar lipids |
PG, PE, PN |
PG, PE, PL, PN |
PG, PE, PL |
PG, PE, PL |
DNA G + C content [mol%] |
57 |
63* |
58 |
66 |
Physiology | ||||
NaCl range (optimum) [% w/v] |
1 – 9 (3) |
0 – 18 (4)* |
1 – 7 (2) |
0.7 – 4.2 (3.5)* |
Temp. range (optimum) [°C] |
12 – 32 (28) |
7 – 40 (37)* |
9 – 33 (28) |
15 – 44 (30)* |
Antibiotic sensitivity | ||||
Imipenem (10 μg) |
+ |
-* |
+ |
- |
Polymyxin B (300 U) |
+ |
+* |
+ |
- |
Required supplements | ||||
L-histidine |
+ |
- |
- |
- |
Biotin |
+ |
+* |
+ |
+ |
Thiamin |
+ |
+* |
+ |
+ |
Vitamin B12 |
+ |
+* |
+ |
+ |
Enzyme activities | ||||
Catalase |
+ |
+ |
w |
+ |
Oxidase |
+ |
+ [-*] |
+ |
+ |
Aesculinase |
- |
- |
- |
+ |
Tweenase 20/80 |
+/w |
+/w |
+/w |
+/+ |
Urease |
- |
- |
+ |
- |
Utilization of | ||||
Sucrose |
- |
- |
+ |
- |
Glycerol |
w |
- |
w |
w [-*] |
Butanol |
+ |
- |
w |
+ |
Propionate |
+ |
+ [-*] |
w |
+ [-*] |
Butyrate |
+ |
+ [-*] |
w |
+ |
DL-lactate |
+ |
- |
- |
+ [-*] |
2-oxoglutarate |
+ |
- |
+ |
+ |
L-serine |
- |
- |
+ |
+ [-*] |
L-proline |
- |
+ |
+ |
- |
L-isoleucine |
- |
+ |
- |
+ |
L-arginine |
- |
- |
+ |
- |
L-phenylalanine |
+ |
- |
- |
- |
L-glutamate |
- |
+ |
+ |
+ [-*] |
L-glutathione | - | + | + | + |
All strains were positive in the utilization of acetate, L-alanine, fumarate, DL-3-hydroxybutyrate, DL-malate, oxaloacetate, pyruvate, succinate, and L-threonine. The following compounds were not utilized by all tested strains: citrate, ethanol, formate, D-fructose, D-glucose, glycolate, and methanol. Degradation of starch and gelatin, reduction of nitrate to nitrite and stimulation of growth by thiosulfate were negative in all strains, as well as diagnostic tests for the enzymes tryptophanase and arginine dihydrolase. Data marked with an asterisk were taken from the literature [18,31]. Published data that disagree with our results are shown in brackets. Abbreviations: PolyP polyphosphate, PHA polyhydroxyalkanoate, CP cyanophycin, GLY glycogen, PG phosphatidylglycerol, PE phosphatidylethanolamine, PL unidentified phospholipid, PN unidentified aminophospholipid, w weakly positive reaction. Strains: 1, Luminiphilus syltensis Ivo14T; 2, Chromatocurvus halotolerans DSM 23344T; 3, Congregibacter litoralis DSM 17192T; 4, Pseudohaliea (= Haliea) rubra DSM 19751T.